Hailei Du

Shanghai Jiao Tong University, Ruijin Hospital

Papers

10

Total Citations

41

H-Index

3

About

Hailei Du is a pioneering thoracic surgeon whose research centers on advancing minimally invasive surgical techniques, particularly robotic-assisted procedures for lung cancer and esophageal diseases. As a key contributor to the landmark RVlob randomized controlled trial (2024, 19 citations), Du provided critical evidence that robotic-assisted lobectomy (RAL) and video-assisted lobectomy (VAL) yield comparable perioperative outcomes and long-term survival for resectable non-small-cell lung cancer—a finding that helps guide surgical decision-making in oncology. Beyond this trial, Du has systematically documented and refined robotic approaches for a wide range of thoracic procedures, including lobectomies, segmentectomies, mediastinal mass resections, and esophagectomies, with multiple technical reports from 2017 demonstrating the safety and feasibility of these methods. This body of work, though early in citation accumulation, establishes Du as a foundational voice in the standardization of robotic thoracic surgery. By sharing detailed operative experiences from Ruijin Hospital, Du has helped demystify robotic techniques for the broader surgical community, accelerating their adoption and improving patient outcomes through reduced complications and shorter hospital stays.

Research Focus

Key Achievements

3
H-Index
10
Papers
41
Total Citations
4
Avg Citations/Paper
🏆 Most Cited Paper
Robotic-assisted versus video-assisted lobectomy for resectable non-small-cell lung cancer: the RVlob randomized controlled trial
19 citations · 2024
📈 Most Prolific Year: 2017 (9 Papers)
🤝 Key Collaborators: 44
🏛 Institutions: Shanghai Jiao Tong University, Ruijin Hospital

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago